Let’s look at the key reasons that are pushing Johnson & Johnson (JNJ) to new highs

Johnson & Johnson (NYSE: JNJ) on Monday, plunged -1.89% from the previous trading day, before settling in for the closing price of $146.62. Within the past 52 weeks, JNJ’s price has moved between $143.13 and $168.85.

Healthcare Sector giant saw their annual sales surged by 1.31% over the last five years. The company achieved an average annual earnings per share of 0.36%. With a float of $2.40 billion, this company’s outstanding shares have now reached $2.41 billion.

The firm has a total of 131900 workers. Let’s measure their productivity. In terms of profitability, gross margin is 69.05%, operating margin of 25.22%, and the pretax margin is 20.1%.

Johnson & Johnson (JNJ) Breakdown of a Key Holders of the stock

Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Johnson & Johnson is 0.12%, while institutional ownership is 72.73%. The most recent insider transaction that took place on Dec 12 ’24, was worth 147,220. In this transaction Director of this company bought 1,000 shares at a rate of $147.22, taking the stock ownership to the 1,000 shares. Before that another transaction happened on Dec 04 ’24, when Company’s Former Officer proposed sale 25,742 for $149.90, making the entire transaction worth $3,858,598.

Johnson & Johnson (JNJ) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 0.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.00% during the next five years compared to -0.27% drop over the previous five years of trading.

Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators

Johnson & Johnson (JNJ) is currently performing well based on its current performance indicators. A quick ratio of 0.79 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.95. Likewise, its price to free cash flow for the trailing twelve months is 16.69.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.05, a number that is poised to hit 2.02 in the next quarter and is forecasted to reach 10.58 in one year’s time.

Technical Analysis of Johnson & Johnson (JNJ)

Analysing the last 5-days average volume posted by the [Johnson & Johnson, JNJ], we can find that recorded value of 9.22 million was better than the volume posted last year of 7.13 million. As of the previous 9 days, the stock’s Stochastic %D was 7.62%. Additionally, its Average True Range was 2.33.

During the past 100 days, Johnson & Johnson’s (JNJ) raw stochastic average was set at 1.30%, which indicates a significant decrease from 2.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 11.43% in the past 14 days, which was lower than the 14.15% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $156.49, while its 200-day Moving Average is $155.21. Now, the first resistance to watch is $146.23. This is followed by the second major resistance level at $148.60. The third major resistance level sits at $149.96. If the price goes on to break the first support level at $142.50, it is likely to go to the next support level at $141.14. Now, if the price goes above the second support level, the third support stands at $138.77.

Johnson & Johnson (NYSE: JNJ) Key Stats

Market capitalization of the company is 346.34 billion based on 2,407,623K outstanding shares. Right now, sales total 85,159 M and income totals 35,153 M. The company made 22,471 M in profit during its latest quarter, and 2,694 M in sales during its previous quarter.